回盛生物：醋酸氯己定软胶囊获得新兽药注册证书

Core Viewpoint - The approval of "Chlorhexidine Acetate Soft Capsules" as a new veterinary drug by the Ministry of Agriculture and Rural Affairs of the People's Republic of China marks a significant development for the company and the veterinary pharmaceutical industry [1]. Company Summary - Wuhan Huisheng Biotechnology Co., Ltd. and its subsidiaries have jointly applied for the new veterinary drug, which has now received official registration [1]. - The new veterinary drug is aimed at treating conditions in pigs, specifically vaginitis caused by sensitive bacteria, and preventing postpartum uterine infections and endometritis [1]. Industry Summary - The approval of new veterinary drugs like Chlorhexidine Acetate Soft Capsules reflects ongoing advancements in the veterinary pharmaceutical sector, enhancing treatment options for livestock [1]. - The regulatory framework under which the drug was approved includes the "Veterinary Drug Management Regulations" and the "Veterinary Drug Registration Measures," indicating a structured approach to drug approval in the industry [1].